State-of-the-Art Obesity Management in the Primary Care Setting

September 28, 2023
Bayhealth - Family Medicine Residency - Dover, DE
The prevalence of obesity among US adults is ~40% and is predicted to reach almost 50% by 2030. Considering the wide range of complications associated with obesity (eg, hypertension, dyslipidemia, gall bladder disease, heart disease, stroke, liver disease, type 2 diabetes, osteoarthritis, sleep apnea, respiratory problems, and many cancers), management of this chronic disease is vital. However, it is apparent that diagnosis and management of patients with obesity is suboptimal. Obesity is underdiagnosed because it is not viewed as a treatment target, and HCPs have suboptimal knowledge of current screening guidelines and best methods to implement screening measures with patients who may be reluctant to discuss weight issues. Indeed, HCPs may communicate poorly with patients regarding weight loss and evidence-based obesity treatments, including anti-obesity medications (AOMs). HCPs only rarely incorporate AOMs in management plans, indicating a failure to adhere to treatment guidelines that recommend the use of pharmacotherapy for patients who have not met weight loss goals (≥5% of total body weight at 3-6 months) with lifestyle intervention alone. In addition, when considering the growing number of pharmacologic treatment options, HCPs need to be aware of the AOMs currently approved, as well as those in late-stage clinical development, and how these might aid patients with obesity succeed in a weight loss program. Knowledge of the different agents, efficacy and safety profiles, administration characteristics, and mechanisms of action will allow clinicians to provide appropriate patient-centered care incorporating pharmacologic therapies along with the lifestyle and behavioral interventions that are the cornerstones of weight loss management.

Educational Partner: Academy for Continued Healthcare Learning (ACHL)

Commercial Support: Support for this activity has been provided through an educational grant from Lilly.

Target Audience

This activity is intended for the multidisciplinary clinical team managing patients with obesity in the primary care practice setting.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Describe the current guideline recommended strategies for screening for obesity in clinical practice and methods to improve diagnosis of obesity as a treatable chronic disease;
  • Analyze recent efficacy and safety outcomes of clinical trials with anti-obesity medications (AOMs);
  • Illustrate methods to engage appropriate patients in discussion on available lifestyle modifications and weight loss strategies which may include the use of AOMs.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
CME Coordinator Contact Phone: 
877-444-8435 ext 160
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Event starts: 
09/28/2023 - 12:00pm
Event ends: 
09/28/2023 - 1:00pm
Activity opens: 
Activity expires: 
Dover, DE
United States
Visit the Academy for Continued Healthcare Learning (ACHL) website!
Contact ACHL via their website.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
  Caroline Apovian, MD
  Professor of Medicine
  Harvard Medical School
  Co-Director, Center for Weight Management and Wellness
  Brigham and Women’s Hospital
  Boston, MA
  Silvana Pannain, MD
  Associate Professor
  Obesity Medicine Director for the Center for Weight and Metabolic Health
  University of Chicago
  Chicago, IL
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School Of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
REGISTRATION: Registration is not open to the public.
For questions or more information visit the ACHL website or click the button below!
Please login or create an account to proceed.